The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gahring, L. C.
Right arrow Articles by Rogers, S. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gahring, L. C.
Right arrow Articles by Rogers, S. W.
The Journal of Immunology, 2001, 166: 1433-1438.
Copyright © 2001 by The American Association of Immunologists


CUTTING EDGE

Cutting Edge: Granzyme B Proteolysis of a Neuronal Glutamate Receptor Generates an Autoantigen and Is Modulated by Glycosylation1

Lorise C. Gahring2, Noel G. Carlson, Erin L. Meyer and Scott W. Rogers2

Geriatric Research Education and Clinical Center, Salt Lake City Veterans Affairs Medical Center and University of Utah School of Medicine, Salt Lake City, Utah, 84112

Autoimmune processes are initiated when tolerance to self-proteins fails to be established or maintained and immune cells are stimulated by self-Ags. Although intracellular autoantigens are common, the origin of extracellular autoantigens is poorly defined and possibly more dangerous. In this study, we considered a mechanism for the origin of an extracellular autoantigen from the neuronal glutamate receptor subunit 3 (GluR3) in Rasmussen’s encephalitis, a severe form of pediatric epilepsy. We demonstrate that specific cleavage of GluR3 by granzyme B (GB), a serine protease released by activated immune cells, can generate the GluR3B autoantigenic peptide, but only if an internal N-linked glycosylation sequon within the GluR3-GB recognition sequence (ISND*S) is not glycosylated. However, this N-glycon sequon while glycosylated normally is inefficiently used and glycosylation can fail. These results suggest that GB/N-glycon sites may escape normal tolerance mechanisms and contribute to autoantibody-mediated immune diseases.




This article has been cited by other articles:


Home page
Ther Adv Respir DisHome page
D. A. Ngan, S. V. Vickerman, D. J. Granville, S. F. P. Man, and D. D. Sin
The possible role of granzyme B in the pathogenesis of chronic obstructive pulmonary disease
Therapeutic Advances in Respiratory Disease, June 1, 2009; 3(3): 113 - 129.
[Abstract] [PDF]


Home page
J. Immunol.Home page
Y. Ganor, V. I. Teichberg, and M. Levite
TCR Activation Eliminates Glutamate Receptor GluR3 from the Cell Surface of Normal Human T Cells, via an Autocrine/Paracrine Granzyme B-Mediated Proteolytic Cleavage
J. Immunol., January 15, 2007; 178(2): 683 - 692.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
U. Specks, D. N. Fass, J. D. Finkielman, A. M. Hummel, M. A. Viss, R. D. Litwiller, and C. J. Mcdonald
Functional Significance of Asn-linked Glycosylation of Proteinase 3 for Enzymatic Activity, Processing, Targeting, and Recognition by Anti-neutrophil Cytoplasmic Antibodies
J. Biochem., January 1, 2007; 141(1): 101 - 112.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Conte, A. Arcaro, D. D'Angelo, A. Gnata, G. Mamone, P. Ferranti, S. Formisano, and F. Gentile
A Single Chondroitin 6-Sulfate Oligosaccharide Unit at Ser-2730 of Human Thyroglobulin Enhances Hormone Formation and Limits Proteolytic Accessibility at the Carboxyl Terminus: POTENTIAL INSIGHTS INTO THYROID HOMEOSTASIS AND AUTOIMMUNITY
J. Biol. Chem., August 4, 2006; 281(31): 22200 - 22211.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. S. Buzza, L. Zamurs, J. Sun, C. H. Bird, A. I. Smith, J. A. Trapani, C. J. Froelich, E. C. Nice, and P. I. Bird
Extracellular Matrix Remodeling by Human Granzyme B via Cleavage of Vitronectin, Fibronectin, and Laminin
J. Biol. Chem., June 24, 2005; 280(25): 23549 - 23558.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
C. L. Palmer, L. Cotton, and J. M. Henley
The Molecular Pharmacology and Cell Biology of {alpha}-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptors
Pharmacol. Rev., June 1, 2005; 57(2): 253 - 277.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
C. G. Bien, T. Granata, C. Antozzi, J. H. Cross, O. Dulac, M. Kurthen, H. Lassmann, R. Mantegazza, J.-G. Villemure, R. Spreafico, et al.
Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: A European consensus statement
Brain, March 1, 2005; 128(3): 454 - 471.
[Abstract] [Full Text] [PDF]


Home page
Plant CellHome page
R. A.L. van der Hoorn, B. B.H. Wulff, S. Rivas, M. C. Durrant, A. van der Ploeg, P. J.G.M. de Wit, and J. D.G. Jones
Structure-Function Analysis of Cf-9, a Receptor-Like Protein with Extracytoplasmic Leucine-Rich Repeats
PLANT CELL, March 1, 2005; 17(3): 1000 - 1015.
[Abstract] [Full Text] [PDF]


Home page
CROBMHome page
A. Rosen and L. Casciola-Rosen
ALTERED AUTOANTIGEN STRUCTURE IN SJoGREN'S SYNDROME: IMPLICATIONS FOR THE PATHOGENESIS OF AUTOIMMUNE TISSUE DAMAGE
Critical Reviews in Oral Biology & Medicine, May 1, 2004; 15(3): 156 - 164.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
Y. Takahashi, H. Mori, M. Mishina, M. Watanabe, T. Fujiwara, J. Shimomura, H. Aiba, T. Miyajima, Y. Saito, A. Nezu, et al.
Autoantibodies to NMDA receptor in patients with chronic forms of epilepsia partialis continua
Neurology, October 14, 2003; 61(7): 891 - 896.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. B. Ulanet, M. Torbenson, C. V. Dang, L. Casciola-Rosen, and A. Rosen
Unique conformation of cancer autoantigen B23 in hepatoma: A mechanism for specificity in the autoimmune response
PNAS, October 14, 2003; 100(21): 12361 - 12366.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. L. Meyer, N. Strutz, L. C. Gahring, and S. W. Rogers
Glutamate Receptor Subunit 3 Is Modified by Site-specific Limited Proteolysis Including Cleavage by {gamma}-Secretase
J. Biol. Chem., June 20, 2003; 278(26): 23786 - 23796.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Ganor, M. Besser, N. Ben-Zakay, T. Unger, and M. Levite
Human T Cells Express a Functional Ionotropic Glutamate Receptor GluR3, and Glutamate by Itself Triggers Integrin-Mediated Adhesion to Laminin and Fibronectin and Chemotactic Migration
J. Immunol., April 15, 2003; 170(8): 4362 - 4372.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. E. Hirst, M. S. Buzza, C. H. Bird, H. S. Warren, P. U. Cameron, M. Zhang, P. G. Ashton-Rickardt, and P. I. Bird
The Intracellular Granzyme B Inhibitor, Proteinase Inhibitor 9, Is Up-Regulated During Accessory Cell Maturation and Effector Cell Degranulation, and Its Overexpression Enhances CTL Potency
J. Immunol., January 15, 2003; 170(2): 805 - 815.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. L. Meyer, L. C. Gahring, and S. W. Rogers
Nicotine Preconditioning Antagonizes Activity-dependent Caspase Proteolysis of a Glutamate Receptor
J. Biol. Chem., March 22, 2002; 277(13): 10869 - 10875.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.